XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Condensed Consolidated Statements of Operations    
PEDMARK product sales, net $ 7,419 $ 1,677
Licensing revenue 17,958  
Total revenue 25,377 1,677
Operating expenses:    
Cost of product sales 550 95
Research and development 3 4
Selling and marketing 5,209 2,531
General and administrative 5,872 4,317
Total operating expenses 11,634 6,947
Net income/(loss) from operations 13,743 (5,270)
Other (expense)/income    
Unrealized foreign exchange (loss)/gain (38) 9
Amortization expense (20) (72)
Unrealized loss on securities (11) (30)
Interest income 197 109
Interest expense (1,034) (798)
Total other expense (906) (782)
Net income/(loss) from operations $ 12,837 $ (6,052)
Basic net income/(loss) per common share $ 0.41 $ (0.23)
Diluted net income/(loss) per common share $ 0.41 $ (0.23)
Weighted-average number of common shares outstanding basic 27,045 26,559
Weighted-average number of common shares outstanding diluted 31,091 26,559